Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
31 Leser
Artikel bewerten:
(0)

Pa. Atty. Gen. Should Drop Case Against Woman Who Cared for Her Dying Father

Compassion & Choices Lawyers Say State's Case Has No Legal Foundation After Hearing

POTTSVILLE, Pa., Aug. 1, 2013 /PRNewswire-USNewswire/ -- Following a preliminary hearing today, legal experts from the nation's leading end-of-life choice group urged the Pennsylvania Attorney General's office to drop an assisted suicide charge against a woman who was present when her 93-year-old, terminally ill father ingested morphine to relieve his pain and later died because the case has no legal foundation. Authorities allege that Barbara Mancini, a registered nurse from Philadelphia, handed her father, Joe Yourshaw of Pottsville, a partially filled bottle of morphine at his request. They claim that this act constitutes "assisted suicide."

"Joe Yourshaw was a 93-year-old man who was very near the end of his life. It defies common sense to charge his daughter with a crime for his death," said Barbara Coombs Lee, President of Compassion & Choices, who worked as an ER and ICU nurse during her 25 years in medicine. "If the government is willing to prosecute Barbara Mancini for caring for her dying father, then we're all in trouble. Attorney General Kane should leave Barbara and her family alone so they can grieve over their loss."

Joe Yourshaw was dying. He suffered from multiple medical conditions that caused him extreme pain: end stage diabetes, extensive heart and cardiovascular disease, stroke, kidney disease, and arthritis. Dying patients have a constitutional right to adequate pain medication, even if it advances the time of death. The U.S. Supreme Court recognized this right in two landmark cases, Washington v. Glucksberg and Vacco v. Quill, both brought by Compassion & Choices' predecessor organization, Compassion in Dying.

"Attorney General Kane has said that she ethically cannot defend an unconstitutional law," said Kathryn Tucker, Director of Legal Affairs and Advocacy for Compassion & Choices and lead counsel in Washington v. Glucksberg and Vacco v. Quill. "The U.S. Supreme court has recognized the constitutional right of dying patients to adequate pain relief even if it advances the time of death. Kane should respect Joe's right to ingest his pain medication and not prosecute a loving daughter who was at her dying father's bedside when he exercised this constitutional right."

A visiting hospice nurse, who arrived shortly after Yourshaw ingested the medication, called 911, despite the fact that he had a Do Not Resuscitate order. He was revived at the hospital, but died there four days later after contracting pneumonia. Ironically, hospital doctors prescribed more morphine to treat his symptoms before he died.

Compassion & Choices is urging concerned citizens who want to stop this unjust prosecution to contact Attorney General Kane to urge her to drop the case. You can call her office at 717-787-3391 and/or email a letter to her by visiting www.compassionandchoices.org.

With over 30 local groups and 40,000 members and supporters throughout the United States, Compassion & Choices leads the end-of-life choice movement. We support, educate and advocate. Learn more at www.compassionandchoices.org.

Contact: Sean Crowley, 202-495-8520-c, scrowley@compassionandchoices.org

SOURCE Compassion & Choices

© 2013 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.